Spending 30 minutes on a treadmill or an elliptical machine a few times each week is not the key to a healthy lifestyle. What’s more important is getting out of your chair, or off the couch, and moving throughout the day – preferably at least once an hour. That’s the logic behind Anytime Fitness’ new “Every Step Counts” campaign – which features reserved parking spots for its members as far away as possible from the gym, in the far corners of the parking lot.
“We care what you do outside the gym every bit as much as when you’re inside one of our facilities,” said Chuck Runyon, CEO and co-founder of Anytime Fitness. “Three hours of rigorous exercise a week is great. But what you do during the other 165 hours each week will really determine whether you’re healthy or not. If you sit in a chair and stare at a computer screen for eight hours a day, without moving every hour or so, then research* shows you’re much more likely to develop a long list of preventable chronic diseases. Sitting too much is the new smoking.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7942951-anytime-fitness-every-step-counts/
At the heart of Ketel One Vodka lies one family’s unwavering passion for crafting the world’s finest spirits. Inspired by over 325 years of distilling expertise, the Nolet family brings old-world pot still craft and modern distilling techniques together in one flawless process. From Joannes to Jacobus to Carolus Sr., creator of Ketel One Vodka, to Carolus Jr. and Bob Nolet today, each of the 11 generations of Nolet family distillers is tasked with upholding a legacy of distilling excellence. Some may consider the Nolets a little obsessive, but those individuals just don’t understand. Everything must be done with meticulous attention to detail, because the family name is riding on every bottle of Ketel One Vodka.
“We take our work very seriously, not ourselves,” said Carl Nolet Jr., 11th Generation Nolet Family Distillery. “The stories we tell are all true and based on family events, beliefs and the pressure of upholding 11 generations of legacy for generations to come.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7975151-ketel-one-vodka
Research from CEB (NYSE: CEB), a best practice insight and technology company and the creators of the Challenger™ Selling model, shows that 51 percent of customers who might be willing to buy from a supplier are not willing to advocate for them and help them get deals over the finish line. This is a direct result of the difficult, internal buying process. Unfortunately, sales organizations lack a true understanding of their customers and are unable to simplify the complexities of buying for them.
“Willingness to buy is not the same as willingness to advocate; suppliers need customers to advocate and fight for them to get deals done today,” said Brent Adamson, principal executive advisor at CEB and co-author of The Challenger Sale and The Challenger Customer. “In order to move past ‘good enough’ and ‘status quo,’ suppliers need to go beyond just understanding how customers interact with them, to gaining a thorough understanding of how they work, what is important to them and how they interact with each other.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7427254-ceb-challenge-align-prescribe-b2b-sales-strategy/
HealthCare Partners, a division of DaVita Inc. (NYSE: DVA), a leading independent medical group in the United States, is encouraging Medicare beneficiaries to review their health care coverage during Medicare’s Open Enrollment Period.
From October 15 through December 7, Medicare holds its annual Open Enrollment Period. During this seven-week window, Medicare beneficiaries can make changes to their health and prescription drug plans for the following year.
If you are satisfied with your Medicare coverage, you may wonder how open enrollment applies to you. As the old adage goes, “if it isn’t broke, don’t fix it,” right?
While this may certainly be the case for many things in life, it may not be true about your Medicare coverage. Choosing a Medicare plan is similar to shopping for other insurance; by comparing different plans and rates, you choose the coverage that’s best for you.
To view the multimedia release go to:
http://www.multivu.com/players/English/7920151-healthcare-partners-medicare-open-enrollment/
A blast of colors lit up the sky today at Kennedy Space Center Visitor Complex in Florida above the new Heroes & Legends featuring the U.S. Astronaut Hall of Fame presented by Boeing. But not because of a rocket launch!
A spirited pyrotechnics display marked the opening of the new attraction, which was attended by more than 25 veteran and current NASA astronauts, including revered Gemini and Apollo space program astronauts Buzz Aldrin, James Lovell and Thomas Stafford. They were joined by the adult children of the late-astronauts Alan Shepard and Neil Armstrong, as well as representatives from NASA, The Boeing Company and Delaware North.
To view the multimedia release go to:
http://www.multivu.com/players/English/7973151-kennedy-space-center-heroes-legends/
LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today recognizes that more than one million people in the United States with drug-resistant epilepsy continue to be treated unsuccessfully with drugs, despite the proven effectiveness of non-drug treatment options. LivaNova’s VNS Therapy®, for example, is a medical device treatment specifically designed for people with drug-resistant epilepsy that is already used by more than 85,000 people around the world.
One in three people with epilepsy has the type that is not well controlled with drugs, called drug-resistant epilepsy. For those people, prescribing more medicine is usually not the most effective option. In fact, research shows that if you haven’t found seizure freedom after your first two drugs, there is a 95 percent chance that no drug or combination of drugs will result in seizure freedom.
“Despite what we know about drug-resistant epilepsy, the majority of people affected by this condition will continue to be prescribed additional medications instead of being evaluated for surgery or seen in a specialized epilepsy facility,” said Jason Richey, president of LivaNova’s U.S. Region and general manager of the Neuromodulation Business Franchise. “This treatment gap means over one million individuals in the U.S. with undertreated epilepsy remain at risk for dangerous side effects of continued seizures, including injury, depression, memory issues and death.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7966451-livanova-vns-therapy-epilepsy/
Crystal Farms®, one of the nation’s favorite cheese brands, today announced a new line of shredded cheeses that will help make cooking authentic Hispanic dishes more approachable for consumers.
The new line features four cheese varieties popular for their versatility and melting capabilities important in Hispanic cooking:
Quesadilla – Rich and creamy, Quesadilla cheese can be used in most recipes that call for melting cheese.
Oaxaca – Named after a region in Mexico, Oaxaca melts effortlessly into casseroles, refried beans and soups.
Asadero – A rich Mexican-style melting cheese, Asadero is ideal for adding buttery flavor to queso, enchiladas and your favorite Mexican fare.
Muenster – Though not a traditional Hispanic cheese, Muenster has been adapted to authentic dishes because of its mild flavor and high melting factor.
To view the multimedia release go to:
http://www.multivu.com/players/English/7916651-crystal-farms-hispanic-shredded-cheeses/
The first all-new 2017 Subaru Impreza rolled off the assembly line at Subaru of Indiana Automotive, Inc. (SIA), officially launching the first-ever American-built Impreza from the automaker. The Impreza had historically been produced only in Japan. The start of Impreza production marks the culmination of more than three years of preparation and highlights the consistent growth in Subaru demand in the United States (U.S.). The positive economic impact of that growth is clear in the investment Subaru made to increase SIA’s production capacity and prepare for Impreza production. SIA invested $1.3 billion over the past four years, and hired an additional 1,400 associates in the past year.
“In a time when some manufacturers are moving work out of the United States, we’re proud to be bringing Subaru Impreza production to the heartland of America,” said Tom Easterday, Senior Executive Vice President of SIA. “The move has allowed us to create hundreds of new jobs not only at SIA, but also at our suppliers in Indiana and across the country.”
The all-new 2017 Subaru Impreza is the first vehicle built using the new Subaru Global Platform architecture that is designed to enhance safety, comfort, agility and driving pleasure. Available in sedan and 5-door models, the 2017 Impreza is equipped with new driver assist technology, multimedia features and standard Symmetrical All-Wheel Drive. The new Impreza will be available in base, Premium, Sport and Limited trim lines starting in late 2016.
To view the multimedia release go to:
http://www.multivu.com/players/English/7673252-subaru-impreza-first-2017-american-made/
The health of babies in the United States has taken a step backward as the nation’s preterm birth rate worsened for the first time in eight years, the March of Dimes said today. The U.S. earned a “C” grade on the latest March of Dimes Premature Birth Report Card amidst widening differences in prematurity rates across different races and ethnicities.
“The 2016 March of Dimes Report Card demonstrates that there is an unfair burden of premature birth among specific racial and ethnic groups as well as geographic areas,” says Dr. Jennifer L. Howse, president of the March of Dimes. “The March of Dimes strives for a world where every baby has a fair chance, yet we see this is not the reality for many mothers and babies. Babies in this country have different chances of surviving and thriving simply based on the circumstances of their birth.”
The U.S. preterm birth rate went up from 9.57 to 9.63 in 2015, according to final data from the National Center for Health Statistics (NCHS). Across the country, preterm birth rates were nearly 48 percent higher among black women and more than 15 percent higher among American Indian/Alaska Native women compared to white women.
To view the multimedia release go to:
http://www.multivu.com/players/English/7945951-march-of-dimes-premature-birth-report/
Masaharu Morimoto, famed Japanese chef and star of Food Network’s “Iron Chef America,” made his official Las Vegas debut with Morimoto Las Vegas, now open at MGM Grand. The Las Vegas Strip is officially home to Morimoto and his distinctive Japanese fare from the world’s finest sushi creations to unforgettable dishes that showcase the Iron Chef’s unique ability to meld Eastern and Western flavors. The restaurant offers three distinct dining experiences: sushi bar, main dining room and Teppan tables, defining the luxurious elevation of Japanese cuisine and introducing the first and only iron griddle menu Morimoto offers in his renowned restaurant portfolio.
“Fate brought Morimoto Las Vegas to MGM Grand at an exciting time when the city’s dining scene is flourishing,” said Morimoto. “I’m continually inspired by Las Vegas’ glamour and wanted to create something we haven’t done before with a stimulating culinary show, bold cuisine and delicious drinks that my guests will not soon forget.”
To view the multimedia release go to:
https://www.multivu.com/players/English/7960551-mgm-grand-morimoto-restaurant-grand-opening
The following statement is being issued by Branstetter, Stranch & Jennings, PLLC regarding In re Prograf Antitrust Litigation.
A lawsuit is currently pending claiming that Astellas Pharma US, Inc. (“Astellas” or “Defendant”) violated state antitrust, unfair competition, consumer protection, and unjust enrichment laws of certain states by delaying the availability of a less expensive generic version of the immunosuppressant prescription drug Prograf® (known as tacrolimus). Plaintiffs allege that Defendant’s conduct caused some consumers and third party payors to pay too much for Prograf in certain states from September 3, 2008 to December 31, 2010 (also referred to as the “Class Damage Period”). This lawsuit does not claim that Prograf is unsafe or ineffective. Astellas denies any wrongdoing.
To view the multimedia release go to:
http://www.multivu.com/players/English/7933851-prograf-antitrust-class-action-settlement/
